Report Description
The global urinary incontinence market size was valued at USD 10.9 billion in 2021 and is expected to surpass USD 19.1 billion by 2030, expanding at a CAGR of 6.5% during the forecast period, 2022–2030. The growth of the market is attributed to the wide prevalence of the disorder among the geriatric population and rising spending on the disorder treatment.
Urinary incontinence is a condition of an involuntary urine leakage primarily caused by a broken sphincter or a malfunctioning bladder. The disorder is also known as an overactive bladder as it is closely associated with people having bladder control issues due to weakness of bladder muscles or nerves. Urine leaking problem is most commonly occurred among the older people, especially women and the problem may arise even on exerting some pressure on the bladder due to laughing, coughing, sneezing, or light physical exercises. To women, the cause of the disorder may vary and can happen due to certain and unique body functions such as pregnancy, childbirth, and menopause, which results in weakening muscles and nerves around the bladder. However, being overweight can be a key factor in causing the disorder for both men and women. The severity level of the disorder may differ from one person to another depending on the types of causes, types of the disorder, and age factors. Using appropriate treatment methods, most of urinary incontinence cases can be controlled and even cured. Several devices are available for the treatment and the devices can assist patients for effective management of the disorder.
The COVID-19 pandemic had posed a threat to the market expansion as almost all medical and healthcare institutions including hospitals and clinics have focused on tackling the emerging healthcare burden of coronavirus cases. Patients with urinary incontinence preferred to continue home treatment and avoid visiting hospitals to avoid the risks of the virus spreading. As per several global reports, the number of patients having outpatient tests and treatments and demand for surgical treatment for various kidney and bladder stones had substantially declined during the pandemic.
Market Trends, Drivers, Restraints, and Opportunities
- Rising geriatric population and wide occurrence of urinary disorders among the women population globally are key factors driving the market.
- Rapid development of advanced devices for urinary incontinence treatment and rising demand for minimally invasive operations among patients present other key drivers of the market.
- Growing awareness regarding the effective treatment methods for the disorder and increasing healthcare spending are expected to boost the market during the forecast period.
- Lack of awareness of effective treatment methods and continuation of traditional treatment methods act as major hurdles that can hamper the market.
- Technological advancements for the development of innovative treatment devices and user-friendly disposable products are likely to create several growth opportunities for the market.
Scope of the Report
The report on the global urinary incontinence market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes | Details |
Report Title | Urinary Incontinence Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year | 2021 |
Historic Data | 2019–2020 |
Forecast Period | 2022–2030 |
Segmentation | Types (Urge Urinary Incontinence, Functional Urinary Incontinence, Stress Urinary Incontinence, and Overflow Urinary Incontinence), Products (Devices and Disposables), and End-users (Home Care, Hospitals & Clinics, and Others) |
Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report | Boston Scientific Corporation; Cardinal Health, Inc.; Medtronic plc; Becton, Dickinson and Company; Teleflex Incorporated; Caldera Medical; Coloplast A/S; ConvaTec Group plc; Cook Group Inc.; Johnson and Johnson; Laborie Medical; Asahi Kasei Corporation; Georgia-Pacific LLC; Kimberly-Clark Corporation; Berry Global Inc.; First Quality Enterprises, Inc.; Freudenberg & Co. KG; Unicharm Corporation; Ahlstrom-Munksjo; and Domtar Corporation. |
Market Segment Insights
Stress urinary incontinence segment holds a dominant market share
Based on types, the global urinary incontinence market is divided into urge urinary incontinence, functional urinary incontinence, stress urinary incontinence, and overflow urinary incontinence. The stress urinary incontinence (SUI) segment held a dominant market share in 2021 and is expected to expand at a rapid pace during the forecast period owing to rising incidences of the urinary incontinence type among a large number of the women population worldwide. As per global reports, around 50% of women having urinary incontinence disorder are likely to experience SUI.
Higher rate of disposables consumption drives the disposables segment
In terms of products, the market is bifurcated into devices and disposables. The disposables segment is anticipated to hold a key share of the market in the coming years due to a higher rate of disposables consumption among patients and the availability of low-price disposable treatment products. On the other hand, the devices segment is anticipated to register a robust growth rate in the coming years due to rising spending on advanced device treatment methods due to high rate of treatment success.
High admission rate of the patients boosts the hospitals & clinics segment
On the basis of end-users, the global urinary incontinence market is segregated into home care, hospitals & clinics, and others. The hospitals & clinics segment constituted a dominant market share in 2021 and is projected to register a considerable CAGR during the forecast period due to high admission rate of the patients to hospitals and frequent patient visits to hospitals for treatment. The presence of various specialized medical staff and technicians for the diagnosis and treatment of the disorders along with the availability of advanced treatment devices in hospitals and clinics further boost the segment.
North America is anticipated to constitute a key market share
In terms of regions, the global urinary incontinence market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to constitute a key share of the market during the projected period owing to the presence of a wide pool of geriatric population and rising cases of urinary incontinence in the region. The early adoption of novel devices for the treatment of the disorder and rising spending in the healthcare sector present other key drivers of the regional market. On the other hand, the Asia Pacific market is anticipated to expand at a rapid pace during the forecast period owing to increasing awareness about the advanced treatment methods for the disorder and rising healthcare expenditure among a large portion of the population in the region.
Segments
Segments Covered in the Report
The global urinary incontinence market has been segmented on the basis of
Types
- Urge Urinary Incontinence
- Functional Urinary Incontinence
- Stress Urinary Incontinence
- Overflow Urinary Incontinence
Products
End-users
- Home Care
- Hospitals & Clinics
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Boston Scientific Corporation
- Cardinal Health, Inc.
- Medtronic plc
- Becton, Dickinson and Company
- Teleflex Incorporated
- Caldera Medical
- Coloplast A/S
- ConvaTec Group plc
- Cook Group Inc.
- Johnson and Johnson
- Laborie Medical
- Asahi Kasei Corporation
- Georgia-Pacific LLC
- Kimberly-Clark Corporation
- Berry Global Inc.
- First Quality Enterprises, Inc.
- Freudenberg & Co. KG
- Unicharm Corporation
- Ahlstrom-Munksjo
- Domtar Corporation
Competitive Landscape
Key players competing in the global urinary incontinence market are Boston Scientific Corporation; Cardinal Health, Inc.; Medtronic plc; Becton, Dickinson and Company; Teleflex Incorporated; Caldera Medical; Coloplast A/S; ConvaTec Group plc; Cook Group Inc.; Johnson and Johnson; Laborie Medical; Asahi Kasei Corporation; Georgia-Pacific LLC; Kimberly-Clark Corporation; Berry Global Inc.; First Quality Enterprises, Inc.; Freudenberg & Co. KG; Unicharm Corporation; Ahlstrom-Munksjo; and Domtar Corporation.
Frequently Asked Questions
Key players of the market are Boston Scientific Corporation; Cardinal Health, Inc.; Medtronic plc; Becton, Dickinson and Company; Teleflex Incorporated; Caldera Medical; Coloplast A/S; ConvaTec Group plc; Cook Group Inc.; and Johnson and Johnson.
North America is expected to account for a key share of the market during the projected period.
The stress urinary incontinence (SUI) segment held a dominant market share in 2021 and is expected to constitute a key share of the market during the forecast period.
Key players of the market include the wide prevalence of the disorder among the geriatric population and rising spending on the disorder treatment.
The global urinary incontinence market size was valued at USD 10.9 billion in 2021 and is expected to surpass USD 19.1 billion by 2030.
Table Of Content
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Urinary Incontinence Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Urinary Incontinence Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Urinary Incontinence Market - Supply Chain
4.5. Global Urinary Incontinence Market Forecast
4.5.1. Urinary Incontinence Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Urinary Incontinence Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Urinary Incontinence Market Absolute $ Opportunity
5. Global Urinary Incontinence Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Urinary Incontinence Market Size and Volume Forecast by Types
5.3.1. Urge Urinary Incontinence
5.3.2.
Functional Urinary Incontinence
5.3.3.
Stress Urinary Incontinence
5.3.4.
Overflow Urinary Incontinence
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Urinary Incontinence Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Urinary Incontinence Market Size and Volume Forecast by End Users
6.3.1. Home Care
6.3.2.
Hospitals & Clinics
6.3.3.
Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Urinary Incontinence Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Urinary Incontinence Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Urinary Incontinence Demand Share Forecast, 2019-2026
8. North America Urinary Incontinence Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Urinary Incontinence Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Urinary Incontinence Market Size and Volume Forecast by Types
8.4.1. Urge Urinary Incontinence
8.4.2.
Functional Urinary Incontinence
8.4.3.
Stress Urinary Incontinence
8.4.4.
Overflow Urinary Incontinence
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Urinary Incontinence Market Size and Volume Forecast by End Users
8.7.1. Home Care
8.7.2.
Hospitals & Clinics
8.7.3.
Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Urinary Incontinence Demand Share Forecast, 2019-2026
9. Latin America Urinary Incontinence Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Urinary Incontinence Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Urinary Incontinence Market Size and Volume Forecast by Types
9.4.1. Urge Urinary Incontinence
9.4.2.
Functional Urinary Incontinence
9.4.3.
Stress Urinary Incontinence
9.4.4.
Overflow Urinary Incontinence
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Urinary Incontinence Market Size and Volume Forecast by End Users
9.7.1. Home Care
9.7.2.
Hospitals & Clinics
9.7.3.
Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Urinary Incontinence Demand Share Forecast, 2019-2026
10. Europe Urinary Incontinence Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Urinary Incontinence Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Urinary Incontinence Market Size and Volume Forecast by Types
10.4.1. Urge Urinary Incontinence
10.4.2.
Functional Urinary Incontinence
10.4.3.
Stress Urinary Incontinence
10.4.4.
Overflow Urinary Incontinence
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Urinary Incontinence Market Size and Volume Forecast by End Users
10.7.1. Home Care
10.7.2.
Hospitals & Clinics
10.7.3.
Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Urinary Incontinence Demand Share Forecast, 2019-2026
11. Asia Pacific Urinary Incontinence Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Urinary Incontinence Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Urinary Incontinence Market Size and Volume Forecast by Types
11.4.1. Urge Urinary Incontinence
11.4.2.
Functional Urinary Incontinence
11.4.3.
Stress Urinary Incontinence
11.4.4.
Overflow Urinary Incontinence
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Urinary Incontinence Market Size and Volume Forecast by End Users
11.7.1. Home Care
11.7.2.
Hospitals & Clinics
11.7.3.
Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Urinary Incontinence Demand Share Forecast, 2019-2026
12. Middle East & Africa Urinary Incontinence Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Urinary Incontinence Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Urinary Incontinence Market Size and Volume Forecast by Types
12.4.1. Urge Urinary Incontinence
12.4.2.
Functional Urinary Incontinence
12.4.3.
Stress Urinary Incontinence
12.4.4.
Overflow Urinary Incontinence
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Urinary Incontinence Market Size and Volume Forecast by End Users
12.7.1. Home Care
12.7.2.
Hospitals & Clinics
12.7.3.
Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Urinary Incontinence Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Urinary Incontinence Market: Market Share Analysis
13.2. Urinary Incontinence Distributors and Customers
13.3. Urinary Incontinence Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Boston Scientific Corporation
13.4.2.
Cardinal Health, Inc.
13.4.3.
Medtronic plc
13.4.4.
Becton, Dickinson and Company
13.4.5.
Teleflex Incorporated
13.4.6.
Caldera Medical
13.4.7.
Coloplast A/S
13.4.8.
ConvaTec Group p